Annual Total Liabilities
$7.88 B
+$1.58 B+25.13%
December 31, 2024
Summary
- As of February 26, 2025, RPRX annual total liabilities is $7.88 billion, with the most recent change of +$1.58 billion (+25.13%) on December 31, 2024.
- During the last 3 years, RPRX annual total liabilities has risen by +$613.03 million (+8.44%).
- RPRX annual total liabilities is now at all-time high.
Performance
RPRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$7.88 B
+$96.57 M+1.24%
December 31, 2024
Summary
- As of February 26, 2025, RPRX quarterly total liabilities is $7.88 billion, with the most recent change of +$96.57 million (+1.24%) on December 31, 2024.
- Over the past year, RPRX quarterly total liabilities has increased by +$1.58 billion (+25.13%).
- RPRX quarterly total liabilities is now -0.31% below its all-time high of $7.90 billion, reached on June 30, 2024.
Performance
RPRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RPRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | +25.1% |
| 3 y3 years | +8.4% | +25.1% |
| 5 y5 years | +24.9% | +25.1% |
RPRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.1% | -0.3% | +25.7% |
| 5 y | 5-year | at high | +28.7% | -0.3% | +29.7% |
| alltime | all time | at high | +28.7% | -0.3% | +29.7% |
Royalty Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $7.88 B(+25.1%) | $7.88 B(+1.2%) |
| Sep 2024 | - | $7.78 B(-1.5%) |
| Jun 2024 | - | $7.90 B(+26.1%) |
| Mar 2024 | - | $6.27 B(-0.5%) |
| Dec 2023 | $6.30 B(-13.6%) | $6.30 B(+0.4%) |
| Sep 2023 | - | $6.27 B(-14.2%) |
| Jun 2023 | - | $7.31 B(+0.8%) |
| Mar 2023 | - | $7.25 B(-0.5%) |
| Dec 2022 | $7.29 B | $7.29 B(+0.4%) |
| Sep 2022 | - | $7.26 B(-1.0%) |
| Jun 2022 | - | $7.33 B(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $7.24 B(-0.4%) |
| Dec 2021 | $7.27 B(+18.7%) | $7.27 B(-1.1%) |
| Sep 2021 | - | $7.35 B(+20.2%) |
| Jun 2021 | - | $6.11 B(+0.5%) |
| Mar 2021 | - | $6.08 B(-0.8%) |
| Dec 2020 | $6.12 B(-2.9%) | $6.12 B(-1.1%) |
| Sep 2020 | - | $6.19 B(-1.6%) |
| Jun 2020 | - | $6.29 B(+1.3%) |
| Mar 2020 | - | $6.21 B(-1.6%) |
| Dec 2019 | $6.31 B(-7.5%) | $6.31 B |
| Dec 2018 | $6.82 B | - |
FAQ
- What is Royalty Pharma annual total liabilities?
- What is the all time high annual total liabilities for Royalty Pharma?
- What is Royalty Pharma annual total liabilities year-on-year change?
- What is Royalty Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Royalty Pharma?
- What is Royalty Pharma quarterly total liabilities year-on-year change?
What is Royalty Pharma annual total liabilities?
The current annual total liabilities of RPRX is $7.88 B
What is the all time high annual total liabilities for Royalty Pharma?
Royalty Pharma all-time high annual total liabilities is $7.88 B
What is Royalty Pharma annual total liabilities year-on-year change?
Over the past year, RPRX annual total liabilities has changed by +$1.58 B (+25.13%)
What is Royalty Pharma quarterly total liabilities?
The current quarterly total liabilities of RPRX is $7.88 B
What is the all time high quarterly total liabilities for Royalty Pharma?
Royalty Pharma all-time high quarterly total liabilities is $7.90 B
What is Royalty Pharma quarterly total liabilities year-on-year change?
Over the past year, RPRX quarterly total liabilities has changed by +$1.58 B (+25.13%)